CN112500345B - Synthetic method of alpha-cyano quaternary carbon substituted tetrahydroisoquinoline compound - Google Patents

Synthetic method of alpha-cyano quaternary carbon substituted tetrahydroisoquinoline compound Download PDF

Info

Publication number
CN112500345B
CN112500345B CN202011504115.6A CN202011504115A CN112500345B CN 112500345 B CN112500345 B CN 112500345B CN 202011504115 A CN202011504115 A CN 202011504115A CN 112500345 B CN112500345 B CN 112500345B
Authority
CN
China
Prior art keywords
cyano
tetrahydroisoquinoline
alpha
quaternary carbon
substituted tetrahydroisoquinoline
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202011504115.6A
Other languages
Chinese (zh)
Other versions
CN112500345A (en
Inventor
姬悦
张学
韩薇薇
王嗣昌
吴亚
刘雪梅
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xian Shiyou University
Original Assignee
Xian Shiyou University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xian Shiyou University filed Critical Xian Shiyou University
Priority to CN202011504115.6A priority Critical patent/CN112500345B/en
Publication of CN112500345A publication Critical patent/CN112500345A/en
Application granted granted Critical
Publication of CN112500345B publication Critical patent/CN112500345B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/22Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
    • C07D217/26Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

The invention belongs to the field of organic synthesis, and discloses a synthesis method of an alpha-cyano quaternary carbon substituted tetrahydroisoquinoline compound. The method has the advantages of simple and practical operation, mild reaction conditions and high yield and purity of the obtained product. The method is suitable for synthesizing isoquinoline compounds, in particular to the synthesis of alpha-cyano quaternary carbon substituted tetrahydroisoquinoline compounds.

Description

Synthetic method of alpha-cyano quaternary carbon substituted tetrahydroisoquinoline compound
Technical Field
The invention belongs to the field of organic synthesis, and relates to a synthetic method of isoquinoline compounds, in particular to a synthetic method of alpha-cyano quaternary carbon substituted tetrahydroisoquinoline compounds.
Background
In the prior art, tetrahydroisoquinoline compounds are widely existed in natural products and bioactive molecules as an important organic amine compound. Chiral tetrahydroisoquinoline alkaloid has excellent bioactivity, is also an important medicine intermediate and is closely related to the life activity of human body. Wherein, the C-1 quaternary carbon substituted tetrahydroisoquinoline compound has rich biological activity. For example, the quaternary carbon-substituted tetrahydroisoquinoline compound MK-801 at C-1, also known as dezociclopine/diniconine (dizocilpine), belongs to a potent and highly selective NMDA (N-methyl-D-aspartic acid) receptor antagonist, and has anesthetic, anticonvulsant and antiepileptic effects as a central nervous system drug. Secondly, the derivative DNLCA of the alpha-cyano quaternary carbon substituted tetrahydroisoquinoline is a non-competitive dopamine beta-hydroxylase inhibitor, has an important effect on controlling epinephrine synthesis, and can be used as a blood pressure lowering medicine; the derivative NLCA is detected in urine of a Parkinson patient treated by levodopamine, cerebellum and urine of a mouse, and has an important effect in treating Parkinson diseases. In addition, a large number of researches show that the alpha-cyano quaternary carbon substituted tetrahydroisoquinoline compound has rich physiological activity and is an important potential central nervous system medicament.
However, the synthesis of α -cyanoquaternary carbon-substituted tetrahydroisoquinolines has not been widely studied, and only a few examples have been reported. The synthesis of the alpha-cyano quaternary carbon substituted tetrahydroisoquinoline is realized mainly by two ways: one is through classical Lewis acid catalyzed Pictet-Spengler cyclization reaction, directly construct the skeleton of the tetrahydroisoquinoline and synthesize 1, 1-disubstituted tetrahydroisoquinoline; the second method is based on the existing tetrahydroisoquinoline skeleton compound, the C1 site proton is extracted under the alkaline condition, and the alpha-cyano quaternary carbon substituted tetrahydroisoquinoline is synthesized through electrophilic substitution or electrophilic addition reaction.
Although the synthesis research of the alpha-cyano quaternary carbon-substituted tetrahydroisoquinoline has made a certain research progress, there still exist some problems, for example, the reaction conditions are harsh, the substrate application range is narrow, the introduction and removal of the protective agent makes the reaction process complicated and by-products increase, and the like, so that the research of an efficient synthesis method for synthesizing the alpha-cyano quaternary carbon-substituted tetrahydroisoquinoline compound has important research value and practical significance.
Disclosure of Invention
In order to solve the above disadvantages in the prior art, the present invention aims to provide a method for synthesizing alpha-cyano quaternary carbon substituted tetrahydroisoquinoline, so as to achieve the purpose of synthesizing alpha-cyano quaternary carbon substituted tetrahydroisoquinoline by using reaction conditions which are simple and convenient to operate, mild and environment-friendly.
In order to achieve the purpose, the technical scheme adopted by the invention is as follows:
adding isoquinoline compounds into an organic solvent, adding methyl iodide, heating, carrying out salification activation, cooling to room temperature, adding a cyano source, a fluorine reagent and alkali, carrying out addition reaction to obtain the alpha-cyano quaternary carbon substituted tetrahydroisoquinoline,
the chemical reaction formula is as follows:
Figure BDA0002844467300000021
wherein R is an alkane having 1 to 6 carbon atomsA group; r1And R2Are respectively-H and-CH3or-OCH3;Rxis-F, -Cl, -CH3and-OCH3One or two of them;
as a limitation of the present invention, the organic solvent is dichloromethane, 1, 2-dichloroethane, dioxane, toluene or methanol;
as another limitation of the invention, the cyano source is trimethylsilyl cyanide; the molar ratio of the cyano source to the isoquinoline compound is 1-2: 1;
as a third definition of the invention, the fluorine reagent is sodium fluoride or potassium fluoride; the molar ratio of the fluorine reagent to the isoquinoline compound is 1-2: 1;
as a fourth limitation of the present invention, the base is sodium carbonate, lithium carbonate, potassium phosphate, or triethylamine; the molar ratio of the alkali to the isoquinoline compound is 0.34-1: 1;
as a fifth limitation of the present invention, the heating reaction temperature is 30 to 80 ℃, and the reaction time is 30 to 60 min;
as a further limitation of the invention, the addition reaction time is 24-48 h;
due to the adoption of the technical scheme, compared with the prior art, the invention has the following beneficial effects:
(1) the synthesis method of the alpha-cyano quaternary carbon substituted tetrahydroisoquinoline provided by the invention can be directly realized by the in-situ reaction of isoquinoline compounds, and the reaction operation is convenient and practical;
(2) the synthesis method of alpha-cyano quaternary carbon substituted tetrahydroisoquinoline provided by the invention adds a fluorine reagent in the addition reaction process, so that the nucleophilic reaction activity of a cyano source can be increased;
(3) the synthesis method of the alpha-cyano quaternary carbon substituted tetrahydroisoquinoline provided by the invention has the advantages of mild reaction conditions, high activity, easy separation of the product and highest yield of the obtained target product reaching 99%;
in conclusion, the synthesis method of the alpha-cyano quaternary carbon substituted tetrahydroisoquinoline provided by the invention can simply and effectively control the reaction process, separate the product and improve the yield of the target product;
the method is suitable for synthesizing isoquinoline compounds, and is particularly suitable for synthesizing alpha-cyano quaternary carbon substituted tetrahydroisoquinoline.
Drawings
FIG. 1 and FIG. 2 are a hydrogen nuclear magnetic spectrum and a carbon nuclear magnetic spectrum, respectively, of 1-phenyl-1-cyano-2-methyl-1, 2,3, 4-tetrahydroisoquinoline prepared in example 1 of the present invention;
FIG. 3 and FIG. 4 are a hydrogen nuclear magnetic spectrum and a carbon nuclear magnetic spectrum, respectively, of 1-cyano-2-methyl-1- (3-tolyl) -1,2,3, 4-tetrahydroisoquinoline prepared in example 12 of the present invention;
FIG. 5 and FIG. 6 are a hydrogen nuclear magnetic spectrum and a carbon nuclear magnetic spectrum, respectively, of 1-cyano-2-methyl-1- (4-tolyl) -1,2,3, 4-tetrahydroisoquinoline prepared in example 13 of the present invention;
FIG. 7 and FIG. 8 are a hydrogen nuclear magnetic spectrum and a carbon nuclear magnetic spectrum, respectively, of 1-cyano-2-methyl-1- (4-chlorophenyl) -1,2,3, 4-tetrahydroisoquinoline prepared in example 14 of the present invention;
FIG. 9, FIG. 10 and FIG. 11 are a hydrogen nuclear magnetic spectrum, a carbon nuclear magnetic spectrum and a fluorine nuclear magnetic spectrum, respectively, of 1-cyano-2-methyl-1- (4-fluorophenyl) -1,2,3, 4-tetrahydroisoquinoline prepared in example 15 of the present invention;
FIG. 12 and FIG. 13 are a hydrogen nuclear magnetic spectrum and a carbon nuclear magnetic spectrum, respectively, of 1-cyano-2-methyl-1- (4-methoxyphenyl) -1,2,3, 4-tetrahydroisoquinoline prepared in example 16 of the present invention;
FIG. 14 and FIG. 15 are a hydrogen nuclear magnetic spectrum and a carbon nuclear magnetic spectrum, respectively, of 1-phenyl-1-cyano-2, 7-dimethyl-1, 2,3, 4-tetrahydroisoquinoline prepared in example 17 of the present invention;
FIG. 16 and FIG. 17 are a hydrogen nuclear magnetic spectrum and a carbon nuclear magnetic spectrum, respectively, of 1-phenyl-1-cyano-2-methyl-7-methoxy-1, 2,3, 4-tetrahydroisoquinoline prepared in example 18 of the present invention;
FIG. 18 and FIG. 19 are a hydrogen nuclear magnetic spectrum and a carbon nuclear magnetic spectrum, respectively, of 1-phenyl-1-cyano-2, 6, 7-trimethyl-1, 2,3, 4-tetrahydroisoquinoline prepared in example 19 of the present invention.
Detailed Description
Preferred embodiments of the present invention will be described below with reference to the accompanying drawings. It should be understood that the description of the preferred embodiment is only for purposes of illustration and understanding, and is not intended to limit the invention.
Example 1A 1-phenyl-1-cyano-2-methyl-1, 2,3, 4-tetrahydroisoquinoline synthesis method
This example provides a synthesis method of 1-phenyl-1-cyano-2-methyl-1, 2,3, 4-tetrahydroisoquinoline, which comprises weighing 103.7mg of 1-phenyl-3, 4-dihydroisoquinoline and 212.9mg of methyl iodide, adding into 3mL of 1, 2-dichloroethane, stirring continuously to dissolve, heating to 40 deg.C, reacting at 40 deg.C for 30min, stirring continuously and cooling to room temperature, adding 99.2mg of trimethylsilyl cyanide, 58.1mg of potassium fluoride and 26.5mg of sodium carbonate, stirring continuously at room temperature to perform addition reaction for 24h, detecting by TLC after the reaction is finished, extracting the reaction solution with dichloromethane, purifying by column chromatography to obtain 113.7mg of 1-phenyl-1-cyano-2-methyl-1, 2,3, 4-tetrahydroisoquinoline, the nuclear magnetic patterns are shown in figure 1 and figure 2, the yield is 92 percent, and the chemical reaction formula is
Figure BDA0002844467300000051
2-Methyl-1-phenyl-1,2,3,4-tetrahydroisoquinoline-1-carbonitrile:White solid,98%yield.Rf=0.55(petroleum ether/ethyl acetate 5:1).1H NMR(400MHz,CDCl3) δ 7.56(dd, J ═ 7.5,1.8Hz,2H), 7.43-7.27 (m,3H), 7.22-7.09 (m,2H), 7.07-6.94 (m,1H),6.74(d, J ═ 8.0Hz,1H), 3.39-3.23 (m,1H), 3.13-2.94 (m,2H),2.82(dd, J ═ 16.2,1.5Hz,1H),2.26(s,3H) (fig. 1).13C NMR(100MHz,CDCl3) δ 140.8,135.9,134.0,129.3,128.9,128.6,128.6,127.8,126.5,117.1,70.5,49.6,40.7,29.1 (fig. 2).
Example 2 ~ 111-phenyl-1-cyano-2-methyl-1, 2,3, 4-four hydrogen isoquinoline synthesis method
Examples 2 to 11 respectively provide a method for synthesizing 1-phenyl-1-cyano-2-methyl-1, 2,3, 4-tetrahydroisoquinoline, which is substantially the same as example 1 except that the raw materials and some process parameters are different, and the specific data are shown in table 1.
Table 1: examples 2 to 11 provide methods for synthesizing 1-phenyl-1-cyano-2-methyl-1, 2,3, 4-tetrahydroisoquinoline, the parameter tables of which are set forth below
Figure BDA0002844467300000061
The other steps are the same as the example 1, and the obtained products are all 1-phenyl-1-cyano-2-methyl-1, 2,3, 4-tetrahydroisoquinoline with the structural formula
Figure BDA0002844467300000062
Example 12A 1-cyano-2-methyl-1- (3-tolyl) -1,2,3, 4-tetrahydroisoquinoline synthesis method
This example provides a method for synthesizing 1-cyano-2-methyl-1- (3-tolyl) -1,2,3, 4-tetrahydroisoquinoline, which comprises weighing 110.6mg of 1- (3-tolyl) -3, 4-dihydroisoquinoline and 212.9mg of iodomethane, adding into 3mL of 1, 2-dichloroethane, stirring and dissolving continuously, heating to 40 deg.C, reacting at 40 deg.C for 30min, stirring continuously and cooling to room temperature, adding 99.2mg of trimethylsilyl cyanide, 58.1mg of potassium fluoride and 26.5mg of sodium carbonate, stirring continuously and reacting for 48h at room temperature, detecting by TLC after the reaction is finished, extracting the reaction solution with dichloromethane, purifying by column chromatography to obtain 130.3mg of 1-cyano-2-methyl-1- (3-tolyl) -1,2,3, 4-tetrahydroisoquinoline with a yield of 99 percent and a chemical reaction formula of
Figure BDA0002844467300000071
2-Methyl-1-(m-tolyl)-1,2,3,4-tetrahydroisoquinoline-1-carbonitrile:White solid,99%yield.Rf=0.55(petroleumether/ethyl acetate 5:1).1H NMR(400MHz,CDCl3) δ 7.36(s,2H),7.25(s,1H), 7.21-7.09 (m,3H),7.03(t, J ═ 6.9Hz,1H),6.76(d, J ═ 7.9Hz,1H), 3.37-3.24 (m,1H), 3.14-2.95 (m,2H),2.82(d, J ═ 16.0Hz,1H),2.34(s,3H),2.26(s,3H) (fig. 3).13C NMR(100MHz,CDCl3)δ140.7,138.4,136.0,133.9,129.4,129.3,128.9,128.4,128.3,127.8,126.5,125.0,117.2,70.5,49.6,40.8,29.1,21.5 (fig. 4).
Example 13A 1-cyano-2-methyl-1- (4-tolyl) -1,2,3, 4-tetrahydroisoquinoline synthesis method
This example provides a method for synthesizing 1-cyano-2-methyl-1- (4-tolyl) -1,2,3, 4-tetrahydroisoquinoline, which comprises weighing 110.6mg of 1- (4-tolyl) -3, 4-dihydroisoquinoline and 212.9mg of iodomethane, adding into 3mL of 1, 2-dichloroethane, stirring and dissolving continuously, heating to 40 deg.C, reacting at 40 deg.C for 30min, stirring continuously and cooling to room temperature, adding 99.2mg of trimethylsilyl cyanide, 58.1mg of potassium fluoride and 26.5mg of sodium carbonate, stirring continuously and reacting for 48h at room temperature, detecting by TLC after the reaction is finished, extracting the reaction solution with dichloromethane, purifying by column chromatography to obtain 123.6mg of 1-cyano-2-methyl-1- (4-tolyl) -1,2,3, 4-tetrahydroisoquinoline with a yield of 94%, and the chemical reaction formula is
Figure BDA0002844467300000072
2-Methyl-1-(p-tolyl)-1,2,3,4-tetrahydroisoquinoline-1-carbonitrile:White solid,94%yield.Rf=0.56(petroleumether/ethyl acetate 5:1)1H NMR (400MHz, CDCl3) δ 7.43(d, J ═ 7.8Hz,2H),7.16(d, J ═ 8.5Hz,4H),7.03(t, J ═ 7.0Hz,1H),6.75(d, J ═ 7.9Hz,1H), 3.37-3.23 (m,1H), 3.14-2.95 (m,2H),2.81(d, J ═ 16.0Hz,1H),2.35(s,3H),2.26(s,3H) (fig. 5).13C NMR (100MHz, CDCl3) delta 138.5,137.9,136.1,134.0,129.3,128.9,127.8,127.7,126.5,117.3,70.3,49.6,40.7,29.1,21.1 (FIG. 6).
Example 14A 1-cyano-2-methyl-1- (4-chlorophenyl) -1,2,3, 4-tetrahydroisoquinoline synthesis method
This example provides a synthesis method of 1-cyano-2-methyl-1- (4-chlorophenyl) -1,2,3, 4-tetrahydroisoquinoline, which comprises weighing 120.9mg of 1- (4-chlorophenyl) -3, 4-dihydroisoquinoline and 212.9mg of iodomethane, adding into 3mL of 1, 2-dichloroethane, stirring continuously to dissolve, heating to 40 deg.C, reacting at 40 deg.C for 30min, stirring continuously and cooling to room temperature, adding 99.2mg of trimethylsilyl cyanide, 58.1mg of potassium fluoride and 26.5mg of sodium carbonate, stirring continuously at room temperature to carry out addition reaction for 48h, detecting by TLC after the reaction is finished, extracting the reaction solution with dichloromethane by column chromatography, purifying to obtain 132.5mg of 1-cyano-2-methyl-1- (4-chlorophenyl) -1,2,3, 4-tetrahydroisoquinoline with a yield of 94%, and the chemical reaction formula is
Figure BDA0002844467300000081
1-(4-Chlorophenyl)-2-methyl-1,2,3,4-tetrahydroisoquinoline-1-carbonitrile:White solid,94%yield.Rf=0.56(petroleumether/ethyl acetate 5:1).1HNMR(400MHz,CDCl3) δ 7.51(d, J ═ 8.5Hz,2H),7.34(d, J ═ 8.7Hz,2H), 7.22-7.10 (m,2H),7.05(t, J ═ 7.4Hz,1H),6.71(d, J ═ 8.0Hz,1H), 3.36-3.22 (m,1H), 3.14-2.94 (m,2H),2.82(dd, J ═ 16.2,1.5Hz,1H),2.25(s,3H) (fig. 7).13C NMR(100MHz,CDCl3) δ 139.5,135.4,134.6,134.0,129.2,129.1,129.1,128.8,128.0,126.7,116.8,70.0,49.5,40.7,29.0 (fig. 8).
Example 15A 1-cyano-2-methyl-1- (4-fluorophenyl) -1,2,3, 4-tetrahydroisoquinoline synthesis method
This example provides a method for synthesizing 1-cyano-2-methyl-1- (4-fluorophenyl) -1,2,3, 4-tetrahydroisoquinoline, which comprises weighing 112.7mg of 1- (4-fluorophenyl) -3, 4-dihydroisoquinoline and 212.9mg of iodomethane, adding into 3mL of 1, 2-dichloroethane, stirring continuously to dissolve, heating to 40 deg.C, reacting at 40 deg.C for 30min, stirring continuously and cooling to room temperature, adding 99.2mg of trimethylsilyl cyanide, 58.1mg of potassium fluoride and 26.5mg of sodium carbonate, stirring continuously at room temperature to carry out addition reaction for 48h, detecting by TLC after the reaction is finished, extracting the reaction solution by using dichloromethane, purifying to obtain 116.6mg of 1-cyano-2-methyl-1- (4-fluorophenyl) -1,2,3, 4-tetrahydroisoquinoline with a yield of 88%, and the chemical reaction formula is
Figure BDA0002844467300000091
1-(4-Fluorophenyl)-2-methyl-1,2,3,4-tetrahydroisoquinoline-1-carbonitrile:Colorless liquid,88%yield.Rf=0.54(petroleum ether/ethyl acetate 5:1).1H NMR(400MHz,CDCl3) δ 7.55(dd, J ═ 8.6,5.3Hz,2H), 7.24-7.12 (m,2H),7.05(t, J ═ 8.6Hz,3H),6.72(d, J ═ 7.9Hz,1H), 3.35-3.23 (m,1H), 3.13-2.95 (m,2H),2.82(dd, J ═ 16.2,1.4Hz,1H),2.25(s,3H) (fig. 9).13C NMR(100MHz,CDCl3) δ 163.71(d, J ═ 248.2Hz),161.48(s),136.71(d, J ═ 3.2Hz),135.64(s),133.96(s),129.60(d, J ═ 8.3Hz),129.09(d, J ═ 12.9Hz),127.96(s),126.61(s),116.99(s),115.64(s),115.42(s),69.89(s),49.56(s),40.65(s),29.00(s) (fig. 10).19F NMR(376MHz,CDCl3) Delta-113.1 (FIG. 11).
Example 16A 1-cyano-2-methyl-1- (4-methoxyphenyl) -1,2,3, 4-tetrahydroisoquinoline synthesis method
This example provides a method for synthesizing 1-cyano-2-methyl-1- (4-methoxyphenyl) -1,2,3, 4-tetrahydroisoquinoline, which comprises weighing 118.7mg of 1- (4-methoxyphenyl) -3, 4-dihydroisoquinoline and 212.9mg of iodomethane, respectively, adding into 3mL of 1, 2-dichloroethane, stirring and dissolving continuously, heating to 40 deg.C, maintaining 40 deg.C for reaction for 30min, stirring continuously and cooling to room temperature, adding 99.2mg of trimethylsilyl cyanide, 58.1mg of potassium fluoride and 26.5mg of sodium carbonate, stirring continuously at room temperature for addition reaction for 48h, detecting by TLC after the reaction is finished, extracting the reaction solution with dichloromethane, purifying by column chromatography to obtain 128.6mg of 1-cyano-2-methyl-1- (4-methoxyphenyl) -1,2,3, 4-tetrahydroisoquinoline with a yield of 92%, the chemical reaction formula is
Figure BDA0002844467300000101
1-(4-Methoxyphenyl)-2-methyl-1,2,3,4-tetrahydroisoquinoline-1-carbonitrile:White solid,92%yield.Rf=0.45(petroleumether/ethyl acetate 5:1).1H NMR(400MHz,CDCl3)δ7.46(d,J=8.7Hz,2H),7.22–7.10(m,2H),7.09–6.98(m,1H),6.88(d,J=8.9Hz,2H),6.76(d,J=7.9Hz,1H),3.81(s,3H),3.35–3.22(m,1H),3.13–2.95(m,2H),2.81(dd,J ═ 16.2,1.5Hz,1H),2.26(s,3H) (fig. 12).13C NMR(100MHz,CDCl3) δ 159.7,136.1,134.0,132.8,129.3,129.0,128.9,127.8,126.5,117.3,113.8,69.9,55.3,49.6,40.6,29.1 (fig. 13).
Example 17A 1-phenyl-1-cyano-2, 7-dimethyl-1, 2,3, 4-tetrahydroisoquinoline synthesis method
This example provides a synthesis method of 1-phenyl-1-cyano-2, 7-dimethyl-1, 2,3, 4-tetrahydroisoquinoline, which comprises weighing 110.6mg of 1-phenyl-7-methyl-3, 4-dihydroisoquinoline and 212.9mg of iodomethane, adding into 3mL of 1, 2-dichloroethane, stirring and dissolving continuously, heating to 40 deg.C, reacting at 40 deg.C for 30min, stirring continuously and cooling to room temperature, adding 99.2mg of trimethylsilyl cyanide, 58.1mg of potassium fluoride and 26.5mg of sodium carbonate, stirring continuously at room temperature for addition reaction for 48h, detecting by TLC after the reaction is finished, extracting the reaction solution with dichloromethane, purifying by column chromatography to obtain 125.0mg of 1-phenyl-1-cyano-2, 7-dimethyl-1, 2,3, 4-tetrahydroisoquinoline with a yield of 95% and a chemical reaction formula of
Figure BDA0002844467300000111
2,7-Dimethyl-1-phenyl-1,2,3,4-tetrahydroisoquinoline-1-carbonitrile:Colorless liquid,95%yield.Rf=0.58(petroleumether/ethyl acetate 5:1).1H NMR(400MHz,CDCl3) δ 7.65-7.48 (m,2H),7.36(d, J ═ 6.0Hz,3H),7.01(dd, J ═ 22.2,7.8Hz,2H),6.53(s,1H), 3.32-3.19 (m,1H), 3.12-2.92 (m,2H),2.78(d, J ═ 15.8Hz,1H),2.25(s,3H),2.13(s,3H) (fig. 14).13C NMR(100MHz,CDCl3) δ 140.9,136.1,135.6,130.9,129.5,128.9,128.8,128.6,128.5,127.8,117.3,70.5,49.7,40.7,28.7,21.0 (fig. 15).
Example 18A synthetic method of 1-phenyl-1-cyano-2-methyl-7-methoxy-1, 2,3, 4-tetrahydroisoquinoline
This example provides a method for synthesizing 1-phenyl-1-cyano-2-methyl-7-methoxy-1, 2,3, 4-tetrahydroisoquinoline, which comprises weighing 118.7mg of 1-phenyl-7-methyl-3, 4-dihydroisoquinoline and 212.9mg of iodomethane, respectively, adding into 3mL of 1, 2-dichloroethane, stirring and dissolving continuously, heating to 40 deg.C, reacting for 30min, stirring continuously and cooling to room temperature, adding 99.2mg of trimethylsilyl cyanide, 58.1mg of potassium fluoride and 26.5mg of sodium carbonate, stirring continuously and reacting for 48h at room temperature, detecting by TLC, extracting the reaction solution with dichloromethane, purifying by column chromatography to obtain 120.0mg of 1-phenyl-1-cyano-2-methyl-7-methoxy-1, 2,3, 4-tetrahydroisoquinoline with a yield of 86%, and the chemical reaction formula is
Figure BDA0002844467300000112
7-Methoxy-2-methyl-1-phenyl-1,2,3,4-tetrahydroisoquinoline-1-carbonitrile:Colorless liquid,86%yield.Rf=0.50(petroleum ether/ethyl acetate 5:1).1H NMR(400MHz,CDCl3) δ 7.56(d, J ═ 6.2Hz,2H),7.36(d, J ═ 6.5Hz,3H),7.07(d, J ═ 8.4Hz,1H),6.76(dd, J ═ 8.4,1.9Hz,1H),6.24(d, J ═ 1.8Hz,1H),3.59(s,3H), 3.29-3.17 (m,1H), 3.12-2.93 (m,2H),2.76(d, J ═ 15.3Hz,1H),2.25(s,3H) (fig. 16).13C NMR(100MHz,CDCl3) δ 157.9,140.7,136.7,129.9,128.7,128.6,127.8,126.1,117.1,114.3,114.1,70.6,55.2,49.8,40.8,28.3 (fig. 17).
Example 19A 1-phenyl-1-cyano-2, 6, 7-trimethyl-1, 2,3, 4-tetrahydroisoquinoline synthesis method
This example provides a synthesis method of 1-phenyl-1-cyano-2, 6, 7-trimethyl-1, 2,3, 4-tetrahydroisoquinoline, which comprises weighing 117.7mg of 1-phenyl-6, 7-dimethyl-3, 4-dihydroisoquinoline and 212.9mg of methyl iodide, adding into 3mL of 1, 2-dichloroethane, stirring and dissolving continuously, heating to 40 deg.C, reacting for 30min, stirring continuously and cooling to room temperature, adding 99.2mg of trimethylsilyl cyanide, 58.1mg of potassium fluoride and 26.5mg of sodium carbonate, stirring continuously and reacting for 48h at room temperature, detecting by TLC after the reaction is finished, extracting the reaction solution with dichloromethane, purifying by column chromatography to obtain 128.6mg of 1-phenyl-1-cyano-2, 6, 7-trimethyl-1, 2,3, 4-tetrahydroisoquinoline with a yield of 93%, the chemical reaction formula is
Figure BDA0002844467300000121
2,6,7-Trimethyl-1-phenyl-1,2,3,4-tetrahydroisoquinoline-1-carbonitrile:White solid,93%yield.Rf=0.50(petroleum ether/ethyl acetate 5:1).1H NMR(400MHz,CDCl3) δ 7.66-7.48 (m,2H), 7.46-7.28 (m,3H),6.92(s,1H),6.48(s,1H), 3.30-3.16 (m,1H),3.02(ddd, J ═ 15.3,11.9,4.3Hz,2H),2.74(d, J ═ 15.7Hz,1H),2.24(s,3H),2.18(s,3H),2.03(s,3H) (fig. 18).13C NMR(101MHz,CDCl3) δ 141.0,136.6,135.0,133.2,131.2,129.9,128.5,127.8,117.4,70.3,49.8,40.7,28.6,19.4,19.4 (fig. 19).
Although the present invention has been described in detail with reference to the above embodiments, it will be apparent to those skilled in the art that modifications may be made to the embodiments described above, or equivalents may be substituted for elements thereof. Any modification, equivalent replacement, or improvement made within the spirit and principle of the present invention should be included in the protection scope of the present invention.

Claims (6)

1. A synthetic method of alpha-cyano quaternary carbon substituted tetrahydroisoquinoline comprises the steps of adding isoquinoline compounds into an organic solvent, adding methyl iodide, heating, carrying out salification activation, cooling to room temperature, adding a cyano source, a fluorine reagent and a base, carrying out addition reaction, and obtaining the alpha-cyano quaternary carbon substituted tetrahydroisoquinoline,
Figure DEST_PATH_IMAGE002
the chemical reaction formula is as follows:
wherein R is an alkyl group with any one of 1-6 carbon atoms;
R1and R2Are respectively-H and-CH3or-OCH3;
RXis-F, -Cl, -CH3and-OCH3One of (1);
the organic solvent is dichloromethane, 1, 2-dichloroethane, dioxane, toluene or methanol;
the cyano source is trimethyl cyano silane;
the fluorine reagent is sodium fluoride or potassium fluoride;
the alkali is sodium carbonate, lithium carbonate, potassium phosphate or triethylamine.
2. The method for synthesizing an alpha-cyano quaternary carbon-substituted tetrahydroisoquinoline of claim 1, wherein the method comprises: the molar ratio of the cyano source to the isoquinoline compound is 1-2: 1.
3. The method for synthesizing an alpha-cyano quaternary carbon-substituted tetrahydroisoquinoline of claim 1, wherein the method comprises: the molar ratio of the fluorine reagent to the isoquinoline compounds is 1-2: 1.
4. the method for synthesizing an alpha-cyano quaternary carbon-substituted tetrahydroisoquinoline of claim 1, wherein the method comprises: the molar ratio of the alkali to the isoquinoline compound is 0.34-1: 1.
5. The method for synthesizing an alpha-cyano quaternary carbon-substituted tetrahydroisoquinoline of claim 1, wherein the method comprises: the heating reaction is carried out at the temperature of 30-80 ℃ for 30-60 min.
6. The method for synthesizing an alpha-cyano quaternary carbon-substituted tetrahydroisoquinoline of claim 1, wherein the method comprises: the time of the addition reaction is 24-48 h.
CN202011504115.6A 2020-12-18 2020-12-18 Synthetic method of alpha-cyano quaternary carbon substituted tetrahydroisoquinoline compound Active CN112500345B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202011504115.6A CN112500345B (en) 2020-12-18 2020-12-18 Synthetic method of alpha-cyano quaternary carbon substituted tetrahydroisoquinoline compound

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202011504115.6A CN112500345B (en) 2020-12-18 2020-12-18 Synthetic method of alpha-cyano quaternary carbon substituted tetrahydroisoquinoline compound

Publications (2)

Publication Number Publication Date
CN112500345A CN112500345A (en) 2021-03-16
CN112500345B true CN112500345B (en) 2022-06-21

Family

ID=74922460

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202011504115.6A Active CN112500345B (en) 2020-12-18 2020-12-18 Synthetic method of alpha-cyano quaternary carbon substituted tetrahydroisoquinoline compound

Country Status (1)

Country Link
CN (1) CN112500345B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114516835B (en) * 2022-03-07 2023-08-15 西安石油大学 Synthesis method of alpha, alpha-disubstituted tetrahydroisoquinoline compound

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11279153A (en) * 1998-03-27 1999-10-12 Sumikin Chemical Co Ltd Production of isoquinoline reissert

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8921464D0 (en) * 1989-09-22 1989-11-08 Fujisawa Pharmaceutical Co Bicyclic amine compound and a process for the preparation thereof
US5389638A (en) * 1993-09-10 1995-02-14 Abbott Laboratories Tetrahydroisoquinolines as alpha-2 antagonists and biogenic amine uptake inhibitors
BRPI0418462A (en) * 2004-03-12 2007-06-05 Analytecon Sa tetrahydroisoquinoline and terahidrobenzazepine derivatives as inhibitors igf-1r
CN103833631B (en) * 2014-02-27 2016-02-03 内蒙古华天制药有限公司 Tetrahydroisoquinolicompounds compounds is as the application of preparation animal miticide
CN110256342B (en) * 2019-07-16 2022-06-07 河南省科学院化学研究所有限公司 Synthetic method of 2-cyano quinoline derivative

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH11279153A (en) * 1998-03-27 1999-10-12 Sumikin Chemical Co Ltd Production of isoquinoline reissert

Also Published As

Publication number Publication date
CN112500345A (en) 2021-03-16

Similar Documents

Publication Publication Date Title
TW198720B (en)
JP3370985B2 (en) Fumadirole derivative and method for producing the same
US5786355A (en) 4,6-diarylpyrimidine derivatives and salts thereof
JP5507081B2 (en) Method for enantioselective hydrogenation of chromene
JPH09208583A (en) Intermediate useful for producing triazole-based antimycotic agent
NZ521576A (en) Novel cyclic amide derivatives
JPH0637487B2 (en) Antihypertensive agent
EP3851441B1 (en) Process for the preparation of (s)-2-((2-((s)-4-(difluoromethyl)-2-oxooxazolidin-3-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)amino) propanamide
CN109503572A (en) A kind of method of synthesis of indole quinolines
CN112500345B (en) Synthetic method of alpha-cyano quaternary carbon substituted tetrahydroisoquinoline compound
CN114349714A (en) Dibenzodiazepine derivative and preparation method and application thereof
US5723484A (en) Benzopyran compounds as 5-HT2C receptor antagonists
EP0351255A2 (en) Derivatives of 2-[(4-piperidinyl)methyl]-1,2,3,4-tetrahydroisoquinoline, their preparation and their use in therapy
EP0381235B1 (en) Pyrrolidine compound and pharmaceutical use
CZ281714B6 (en) Piperidylmethyl substituted derivatives of chroman, process of their preparation and pharmaceutical composition containing thereof
JP2001048864A (en) COMPOUND FOR PRODUCING beta-ADRENALINE RECEPTOR ANTAGONIST AND METHOD
JP2000026418A (en) New production of derivative of 4-phenyl-1,2,3,6- tetrahydropyridine and intermediate used therefor
FR2634207A1 (en) [(4-Piperidyl)methyl]benzazepine derivatives, their preparation and their application in therapeutics
CN104650022A (en) Synthesis method and intermediate compound of nebivolol
CN109020895B (en) Synthesis method of metal-catalyzed 1-benzylamino-substituted benzimidazole
CN112661668A (en) N-substituted amide compound and preparation method thereof
US6743918B2 (en) Process for producing camptothecin
EA012628B1 (en) 3,3a,8,12b-TETRAHYDRO-2H-DIBENZO[3,4:6,7]CYCLOHEPTA[1,2-B]FURAN
KR20070098882A (en) 5-ht7 receptor antagonists
CN112341398B (en) 1,2,3-triazole substituted chalcone derivative with bioactivity, preparation method and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant